跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33,178 条关于
“Complement Factor B”
全部
33,178
临床试验
19,613
药物
3,057
机构
3,154
资讯
7,354
11个月前
ADARx Pharmaceuticals to Present Phase 1 Data for ADX-038 siRNA Therapy at ASN Kidney Week 2025
7个月前
China Medical System Partners with Insilico Medicine for AI Drug Discovery, Advances Complement Inhibitor to Clinical Trials
去年
Argo Biopharma Advances siRNA Therapy BW-40202 to Phase II Trial for Paroxysmal Nocturnal Hemoglobinuria
去年
Phase 3 Data Shows Iptacopan Eases Fatigue in C5i-Experienced, -Naïve PNH Patients
2个月前
Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors
去年
CDSCO Approves Novartis' Protocol Amendment for Iptacopan Study in Rare Kidney Disorders
去年
Biogen's Felzartamab Shows Promising Results in IgA Nephropathy Phase 2 Trial
去年
Paroxysmal Nocturnal Hemoglobinuria Pipeline Shows Robust Development with 25+ Therapies from Leading Pharmaceutical Companies
去年
Iptacopan Shows Promise in Treating Life-Threatening Transplant-Associated Thrombotic Microangiopathy
11个月前
Wu Yifang Appointed Chairman of Everest Medicines as Company Advances mRNA Cancer Vaccine Platform
第 1 页,共 736 页
上一页
下一页